Cargando…

Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials

BACKGROUND: Our objective was to evaluate the efficacy (clinical and biomarker) and safety of intravenous bapineuzumab in patients with mild to moderate Alzheimer’s disease (AD). METHODS: Two of four phase 3, multicenter, randomized, double-blind, placebo-controlled, 18-month trials were conducted g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vandenberghe, Rik, Rinne, Juha O., Boada, Mercè, Katayama, Sadao, Scheltens, Philip, Vellas, Bruno, Tuchman, Michael, Gass, Achim, Fiebach, Jochen B., Hill, Derek, Lobello, Kasia, Li, David, McRae, Tom, Lucas, Prisca, Evans, Iona, Booth, Kevin, Luscan, Gerald, Wyman, Bradley T., Hua, Lisa, Yang, Lingfeng, Brashear, H. Robert, Black, Ronald S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4866415/ https://www.ncbi.nlm.nih.gov/pubmed/27176461 http://dx.doi.org/10.1186/s13195-016-0189-7

Ejemplares similares

Long-term safety and tolerability of bapineuzumab in patients with Alzheimer’s disease in two phase 3 extension studies
por: Ivanoiu, Adrian, et al.
Publicado: (2016)

Alzheimer's disease progression model using disability assessment for dementia scores from bapineuzumab trials
por: Xu, Steven X., et al.
Publicado: (2015)

Alzheimer's disease assessment scale-cognitive 11-item progression model in mild-to-moderate Alzheimer's disease trials of bapineuzumab
por: Samtani, Mahesh N., et al.
Publicado: (2015)

Amyloid-related imaging abnormalities-haemosiderin (ARIA-H) in patients with Alzheimer's disease treated with bapineuzumab: a historical, prospective secondary analysis
por: Arrighi, H Michael, et al.
Publicado: (2016)

Bapineuzumab for mild to moderate Alzheimer’s disease: a meta-analysis of randomized controlled trials
por: Abushouk, Abdelrahman Ibrahim, et al.
Publicado: (2017)

Bapineuzumab captures the N-terminus of the Alzheimer's disease amyloid-beta peptide in a helical conformation
por: Miles, Luke A., et al.
Publicado: (2013)

Bapineuzumab Alters Aβ Composition: Implications for the Amyloid Cascade Hypothesis and Anti-Amyloid Immunotherapy
por: Roher, Alex E., et al.
Publicado: (2013)

ERRATUM: Bapineuzumab captures the N-terminus of the Alzheimer's disease amyloid-beta peptide in a helical conformation
por: Miles, Luke A., et al.
Publicado: (2013)

Crystal structure reveals conservation of amyloid-β conformation recognized by 3D6 following humanization to bapineuzumab
por: Feinberg, Hadar, et al.
Publicado: (2014)

Targeting Beta Amyloid: A Clinical Review of Immunotherapeutic Approaches in Alzheimer's Disease
por: Lobello, Kasia, et al.
Publicado: (2012)

Recruitment of pre-dementia participants: main enrollment barriers in a longitudinal amyloid-PET study
por: Bader, Ilse, et al.
Publicado: (2023)

Classification of the primary progressive aphasias: principles and review of progress since 2011
por: Vandenberghe, Rik
Publicado: (2016)

Positron Emission Tomography in the Differential Diagnosis of Parkinsonism
por: Rinne, Juha O
Publicado: (2009)

Dissociations between spatial-attentional processes within parietal cortex: insights from hybrid spatial cueing and change detection paradigms
por: Vandenberghe, Rik, et al.
Publicado: (2013)

Cognitive and Behavioral Manifestations in ALS: Beyond Motor System Involvement
por: Rusina, Robert, et al.
Publicado: (2021)

Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer’s disease
por: Bateman, Randall J., et al.
Publicado: (2022)

Active Aβ immunotherapy CAD106 in Alzheimer's disease: A phase 2b study
por: Vandenberghe, Rik, et al.
Publicado: (2016)

Cognitive and Neuropsychiatric Manifestations of COVID-19 and Effects on Elderly Individuals With Dementia
por: Alonso-Lana, Silvia, et al.
Publicado: (2020)

A comparative clinical study of PF-06410293, a candidate adalimumab biosimilar, and adalimumab reference product (Humira®) in the treatment of active rheumatoid arthritis
por: Fleischmann, Roy M., et al.
Publicado: (2018)

Quantitative Analyses Help in Choosing Between Simultaneous vs. Separate EEG and fMRI
por: Schrooten, Maarten, et al.
Publicado: (2019)

Amnestic MCI Patients’ Perspectives toward Disclosure of Amyloid PET Results in a Research Context
por: Vanderschaeghe, Gwendolien, et al.
Publicado: (2017)

Prognostic value of amyloid/tau/neurodegeneration (ATN) classification based on diagnostic cerebrospinal fluid samples for Alzheimer’s disease
por: Delmotte, Koen, et al.
Publicado: (2021)

Imaging neuroinflammation in multiple sclerosis using TSPO-PET
por: Airas, Laura, et al.
Publicado: (2015)

Symptomatic and Disease-Modifying Therapy Pipeline for Alzheimer’s Disease: Towards a Personalized Polypharmacology Patient-Centered Approach
por: Morató, Xavier, et al.
Publicado: (2022)

Stromal vascular fraction therapy for knee osteoarthritis: a systematic review
por: Boada-Pladellorens, Anna, et al.
Publicado: (2022)

Comentario al original ’Adaptación y viabilidad de la versión telemática de la escala Fugl Meyer para la evaluación de pacientes tras accidentes cerebrovasculares
por: Avellanet, Merce, et al.
Publicado: (2022)

A Time-Varying Connectivity Analysis from Distributed EEG Sources: A Simulation Study
por: Ghumare, Eshwar G., et al.
Publicado: (2018)

Direct and indirect selenium speciation in biofortified wheat: A tale of two techniques
por: Subirana, Maria Angels, et al.
Publicado: (2023)

The Anti-Inflammatory Effects of Lipoxygenase and Cyclo-Oxygenase Inhibitors in Inflammation-Induced Human Fetal Glia Cells and the Aβ Degradation Capacity of Human Fetal Astrocytes in an Ex vivo Assay
por: Pihlaja, Rea, et al.
Publicado: (2017)

Associations Between Caffeine Consumption, Cognitive Decline, and Dementia: A Systematic Review
por: Chen, J.Q. Alida, et al.
Publicado: (2020)

Buddy Catheter Technique: A Method of Guiding the Mo.Ma Ultra into a Left Common Carotid Artery That Branches off the Aortic Arch at a Steep Angle
por: Kamamoto, Dai, et al.
Publicado: (2022)

A Case of Carotid Artery Stenting after Aspiration of Thrombus and Unstable Plaque
por: Kubo, Hajime, et al.
Publicado: (2020)

Disentangling the Role of Working Memory in Parkinson’s Disease
por: Salmi, Juha, et al.
Publicado: (2020)

Amnestic MCI patients’ experiences after disclosure of their amyloid PET result in a research context
por: Vanderschaeghe, Gwendolien, et al.
Publicado: (2017)

From information to follow-up: Ethical recommendations to facilitate the disclosure of amyloid PET scan results in a research setting
por: Vanderschaeghe, Gwendolien, et al.
Publicado: (2018)

Glia Imaging Shows Clinical Utility in Differentiating Parkinson's Disease from Multiple System Atrophy
por: Rinne, Juha O., et al.
Publicado: (2022)

Botulinum toxin type A in the treatment of patients with cervical dystonia
por: Brashear, Allison
Publicado: (2009)

The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial
por: Prins, Niels D, et al.
Publicado: (2014)

Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease()
por: Vandenberghe, Rik, et al.
Publicado: (2013)

La producción de la noticia : estudio sobre la construcción de la realidad
por: Tuchman, Gaye

Cannot write session to /tmp/vufind_sessions/sess_0eoik2ttlbfrga4klim6oftenk